Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

Clinical trial NCT04912115 · SUSPENDED

Trial details

NCT number: NCT04912115
Sponsor: PharmaTher Inc.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyskinesias Movement Disorders Central Nervous System Diseases Nervous System Diseases Neurologic Manifestations

Start date: 2021-10-05
Primary completion: 2023-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.